Cambridge Cognition : New £2.2 million contract for at-home cognitive testing in a virtual clinical trial

This is the second, large, at-home cognitive testing contract the Company has secured in two months. The previous one was announced on 8 April 2021 with a value of £0.5 million.In delivering the contract, the Company will deploy web-based cognitive assessments (CANTAB^TM) monthly. Cognition can fluctuate over the course of a day as well as over longer periods, therefore participants will be asked to periodically undertake short digital cognitive assessments up to three times a day.

Cambridge Cognition is uniquely positioned to secure this contract as its proprietary CANTAB™ cognitive assessments produce comparable performance whether delivered under supervision in clinics or unsupervised at home¹. The Company also offers rapid assessments that have been validated for high-frequency testing on smartphones².

Matthew Stork, Chief Executive Officer of Cambridge Cognition, said:

'As widely predicted, the COVID-19 pandemic has accelerated interest in virtual clinical trial assessments and Cambridge Cognition is well positioned to benefit from the consequent substantial growth opportunities. We are pleased to have secured another large contract for a virtual clinical trial where we will be working with a leading pharmaceutical company in the sector. The Company has established a robust science foundation and an excellent customer service record and this combination continues be rewarded by securing contracts for the growing field of virtual clinical trials.'

References

1. Backx R, Skirrow C, Dente P, Barnett JH, Cormack FK. Comparing Web-Based and Lab-Based Cognitive Assessment Using CANTAB™. J Med Internet Res 2020;22(8):e16792. doi: 10.2196/16792

2. Allen L, Baker E, Thorp E et. Validation and Comparison of a Digital Digit Symbol Substitution (DSST) Task Performed on Smart Phones With a Traditional Paper-Pencil Version. Biological Psychiatry 2020; 88(9). DOI: https://doi.org/10.1016/j.biopsych.2021.02.342